ReviewCardiovascular research2024
SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits.
Alberto Preda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
102 papers cite itlatest 60 shown
this paperpooled ittrialcites it